Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Inovio Pharma (NQ: INO ) 5.670 +0.050 (+0.89%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 6, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Inovio Pharma < Previous 1 2 3 4 5 6 7 8 9 Next > Step Aside AMC: Here Are The Most Shorted Stocks Right Now June 02, 2021 Just like in late January the common theme here is that all these stocks are extremely heavily shorted, and retail investors are seeking to squeeze the shorts once again and this time with even more... Via Talk Markets Ocugen vs. Inovio: Where Is the Smart Money Going? May 23, 2021 They're both seeking share in the vaccine market. Via The Motley Fool Exposures COVID-19 Inovio's Latest COVID Vaccine Results: Too Little, Too Late? May 21, 2021 Maybe not -- especially outside of the U.S. Via The Motley Fool Exposures COVID-19 2 Things That May Boost This Beaten-Down Vaccine Stock May 20, 2021 This company could benefit from a near-term need -- and a long-term one, as well. Via The Motley Fool High Flyers At Much Lower Altitudes May 14, 2021 Stocks with extreme valuations have taken a serious haircut since the space peaked on February 22nd. Via Talk Markets Earnings Scheduled For May 10, 2021 May 10, 2021 Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report... Via Benzinga 1 Coronavirus Vaccine Company to Avoid Like The Plague in May (and Beyond) May 13, 2021 This biotech's prospects look dim. Via The Motley Fool Exposures COVID-19 Inovio's Pan-COVID-19 Vaccine Candidate Can Provide Immune Responses Against Variants, Animal Study Shows May 12, 2021 Inovio Pharmaceuticals Inc (NASDAQ: INO) has announced results from a preclinical study of its next-generation Pan-COVID-19 vaccine candidate, INO-4802, that... Via Benzinga Stocks That Hit 52-Week Lows On Tuesday May 11, 2021 Before 10 a.m. ET Tuesday, 173 stocks hit new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Snowflake (NYSE:SNOW... Via Benzinga The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron May 12, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ... Via Benzinga Exposures COVID-19 Novavax, Inovio Stocks Hammered As Covid Vaccine News Disappoints May 11, 2021 Vaccine stocks crumbled Tuesday after Novavax announced a delay and Inovio's Covid vaccine disappointed in testing. Both NVAX stock and INO stock plunged. Via Investor's Business Daily 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 11, 2021 Gainers Cerecor (NASDAQ:CERC) shares rose 14.56% to $2.91 during Tuesday's pre-market session. The company's market cap stands at $281.4 million. Larimar... Via Benzinga Inovio Pharmaceuticals (INO) Q1 2021 Earnings Call Transcript May 11, 2021 INO earnings call for the period ending March 31, 2021. Via The Motley Fool Topics Earnings Exposures Financial Recap: Inovio Pharmaceuticals Q1 Earnings May 10, 2021 Shares of Inovio Pharmaceuticals (NASDAQ:INO) decreased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share decreased 3.85% over... Via Benzinga Inovio's DNA COVID-19 Vaccine Candidate Triggers Immune Response In Pivotal Study May 10, 2021 Inovio Pharmaceuticals Inc (NASDAQ: INO) has announced positive data from the Phase 2 segment of its Phase 2/3 INNOVATE trial in the U.S.,... Via Benzinga Exposures COVID-19 The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings May 11, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -... Via Benzinga Exposures COVID-19 Product Safety 20 Stocks Moving in Monday's Pre-Market Session May 10, 2021 Gainers Alfi, Inc. (NASDAQ: ALF) shares rose 30.3% to $4.82 in pre-market trading. The company recently appointed Ron Spears as Chief Revenue Officer. SemiLEDs Corporation (... Via Benzinga Preview: Inovio Pharmaceuticals's Earnings May 07, 2021 Inovio Pharmaceuticals (NASDAQ:INO) announces its next round of earnings this Monday, May 10. Here is Benzinga's everything-that-matters guide for this Monday's Q1 earnings... Via Benzinga Stocks That Hit 52-Week Lows On Tuesday May 04, 2021 On Tuesday morning, 58 companies hit new 52-week lows. Points of Interest: The largest company by market cap to set a new 52-week low was Lufax Holding (NYSE:LU).... Via Benzinga The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings May 09, 2021 Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... Via Benzinga Exposures COVID-19 Product Safety The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs May 07, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:... Via Benzinga The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues May 05, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... Via Benzinga Cramer Weighs In On Coinbase, Kellogg And More April 29, 2021 Jim Cramer said on CNBC's "Mad Money Lightning Round" that he has always felt that Ocugen Inc (NASDAQ: OCGN) is a great spec, but it's a heavily shorted stock... Via Benzinga Can Inovio Recover From Its Huge Setback? April 28, 2021 It might be able to, although it won't be easy. Via The Motley Fool Exposures COVID-19 Is There Any Hope for Inovio? April 27, 2021 Everything may depend on an early-stage program. Via The Motley Fool Exposures COVID-19 Market Briefing For Monday, Apr. 26 April 26, 2021 Nasdaq is perking up, primarily led by FANG types reporting next week (discounted). So, higher a bit near-term; then, risks. Via Talk Markets Mid-Afternoon Market Update: Nasdaq Surges 1.5%; EDAP Shares Plunge April 23, 2021 Toward the end of trading Friday, the Dow traded up 0.67% to 34,041.01 while the NASDAQ rose 1.54% to 14,031.45. The S&P also rose, gaining 1.16% to 4,182.83. The U.S. has the... Via Benzinga Topics Stocks Exposures US Equities 50 Biggest Movers From Friday April 26, 2021 Gainers Sypris Solutions, Inc. (NASDAQ: SYPR) shares surged 59.1% to close at $4.47 on Friday after the company said its electronics unit has won a contract for deep space... Via Benzinga Mid-Day Market Update: Skechers Jumps On Earnings Beat; Inovio Pharmaceuticals Shares Drop April 23, 2021 Midway through trading Friday, the Dow traded up 0.52% to 33,992.56 while the NASDAQ rose 0.93% to 13,947.48. The S&P also rose, gaining 0.82% to 4,168.89. The U.S. has the... Via Benzinga Topics Stocks Exposures US Equities 32 Stocks Moving In Friday's Mid-Day Session April 23, 2021 Gainers Sypris Solutions, Inc. (NASDAQ: SYPR) shares climbed 24.7% to $3.50 after the company said its electronics unit has won a contract for deep space program. MicroVision,... Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
